AstraZeneca Denies German Reports on Covid1-19 Vaccine Effectiveness

German daily newspapers Handelsblatt and Bild reported on Monday, that the Pharmaceutical company AstraZeneca vaccine is not very effective for people over 65. In contrast, the AstraZeneca firm has denied German media reports, according to Reuters report.

Moreover, the company noted the United Kingdom's Joint Committee on Vaccination and Immunisation supported the vaccine's use in the elderly. It also added that, strong immune responses to the vaccine had been shown in blood analysis of elderly trial participants.

Meanwhile, the media reports mark another potential issue for AstraZeneca, which told the EU last week it could not meet agreed supply targets up to the end of March after running into production problems.

Later, Australia signed supply orders for the the AstraZeneca vaccine months ago, with the vaccine being manufactured in Australia. On December 30, the UK became the first country to approve the two-shot AstraZenaca vaccine and did not impose an upper age limit.

Also, the firm's main trial in the UK started testing on adults no older than 55, because it initially focused on healthcare personnel and frontline workers in active duty. Noteworthy, the frustration growing among European countries because Pfizer and partner BioNTech announced a temporary slowdown in vaccine supplies earlier on January.